Singular Genomics Systems, Inc. (OMIC) Research

Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.

Market snapshot

Symbol
OMIC
Price
$20.01
Day change
0.00%
Market cap
$50.8M
P/E ratio
-0.51x
52-week range
5.34-23.41
Sector
Healthcare
Industry
Medical - Instruments & Supplies

Peer companies

  • Akso Health Group (AHG)
  • Akoya Biosciences, Inc. (AKYA)
  • AlloVir, Inc. (ALVR)
  • bluebird bio, Inc. (BLUE)
  • Eargo, Inc. (EAR)
  • GlucoTrack, Inc. (GCTK)
  • Kronos Bio, Inc. (KRON)
  • Rein Therapeutics Inc. (RNTX)

Recent insider activity

  • TANG KEVIN — D-Return (372000 shares) on 2025-02-21
  • Spaventa Andrew — D-Return (5271 shares) on 2025-02-21
  • Spaventa Andrew — D-Return (33333 shares) on 2025-02-21
  • Spaventa Andrew — D-Return (42881 shares) on 2025-02-21
  • Spaventa Andrew — D-Return (85 shares) on 2025-02-21

Open Singular Genomics Systems, Inc. (OMIC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.